Diferencia entre revisiones de «Drug pregnancy categories»
| (No se muestran 19 ediciones intermedias de 2 usuarios) | |||
| Línea 3: | Línea 3: | ||
==Background== | ==Background== | ||
*The FDA previously assigned letter categories to medications based on their potential for risk to the fetus | *The FDA previously assigned letter categories to medications based on their potential for risk to the fetus | ||
*New drugs approved after the 2015 PLLR will not be assigned a pregnancy category. | *New drugs approved after the 2015 PLLR will not be assigned a pregnancy category.<ref>Brucker MC, King TL. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule. J Midwifery Womens Health. 2017;62(3):308-316. doi:10.1111/jmwh.12611</ref> | ||
==Table== | ==Table== | ||
| Línea 28: | Línea 28: | ||
*[[Doxylamine]] | *[[Doxylamine]] | ||
*[[Levothyroxine]] | *[[Levothyroxine]] | ||
*[[Isoniazid]] | |||
==Category B Drugs== | ==Category B Drugs== | ||
| Línea 33: | Línea 34: | ||
*[[Penicillin V]], [[Penicillin G Benzathine]], [[Amoxicillin]], [[Amoxicillin/Clavulanate]], [[Oxacillin]], [[Ampicillin]], [[Ampicillin/Sulbactam]], [[Ticarcillin/Clavulanate]], [[Dicloxacillin]], [[Cloxacillin]], [[Nafcillin]] | *[[Penicillin V]], [[Penicillin G Benzathine]], [[Amoxicillin]], [[Amoxicillin/Clavulanate]], [[Oxacillin]], [[Ampicillin]], [[Ampicillin/Sulbactam]], [[Ticarcillin/Clavulanate]], [[Dicloxacillin]], [[Cloxacillin]], [[Nafcillin]] | ||
*[[Ceftriaxone]], [[Cephalexin]], [[Cefazolin]], [[Cefepime]], [[Cefuroxime]], [[Ceftaroline fosamil]], [[Cefdinir]], [[Cefadroxil]], [[Cefpodoxime]], [[Cefprozil]], [[Ceftolozane/tazobactam]], [[Cefditoren]] | *[[Ceftriaxone]], [[Cephalexin]], [[Cefazolin]], [[Cefepime]], [[Cefuroxime]], [[Ceftaroline fosamil]], [[Cefdinir]], [[Cefadroxil]], [[Cefpodoxime]], [[Cefprozil]], [[Ceftolozane/tazobactam]], [[Cefditoren]] | ||
*[[Clindamycin]], [[Azithromycin]], [[Erythromycin]], [[Fidaxomicin]] | *[[Clindamycin]], [[Azithromycin]], [[Erythromycin]], [[Fidaxomicin]], [[Spiramycin]] | ||
*[[Metronidazole]] | *[[Metronidazole]] | ||
*[[Daptomycin]] | *[[Daptomycin]] | ||
| Línea 43: | Línea 44: | ||
===Other Antimicrobials=== | ===Other Antimicrobials=== | ||
*[[Acyclovir]], [[Famciclovir]] | *[[Acyclovir]], [[Famciclovir]] | ||
*[[Valacyclovir]] | |||
*[[Amphotericin B]] | *[[Amphotericin B]] | ||
*[[Clotrimazole]] (topical, vulvovaginal) | *[[Clotrimazole]] (topical, vulvovaginal) | ||
| Línea 50: | Línea 52: | ||
*[[Emtricitabine/tenofovir]] (Truvada) | *[[Emtricitabine/tenofovir]] (Truvada) | ||
*[[Nitazoxanide]] | *[[Nitazoxanide]] | ||
*[[Praziquantel]] | |||
*[[Raxibacumab]] | |||
===Antiemetics and other GI medications=== | ===Antiemetics and other GI medications=== | ||
| Línea 57: | Línea 61: | ||
*[[Famotidine]] | *[[Famotidine]] | ||
*[[Lansoprazole]], [[Pantoprazole]] | *[[Lansoprazole]], [[Pantoprazole]] | ||
*[[Lactulose]] | *[[Lactulose]], [[Psyllium]] | ||
*[[Loperamide]] | *[[Loperamide]] | ||
*[[Dicyclomine]] | *[[Dicyclomine]] | ||
*[[Ursodiol]] | |||
*[[Sucralfate]] | |||
===Analgesics and other neuro/psych meds=== | ===Analgesics and other neuro/psych meds=== | ||
| Línea 81: | Línea 86: | ||
*[[Sildenafil]] | *[[Sildenafil]] | ||
*[[Dobutamine]] | *[[Dobutamine]] | ||
*[[Sotalol]] | |||
===Antiplatelet and Anticoagulants=== | ===Antiplatelet and Anticoagulants=== | ||
| Línea 86: | Línea 92: | ||
*[[Eptifibatide]] | *[[Eptifibatide]] | ||
*[[Ticlopidine]] | *[[Ticlopidine]] | ||
*[[Tirofiban]] | |||
*[[Apixaban]] | *[[Apixaban]] | ||
*[[Argatroban]], [[Bivalirudin]] | *[[Argatroban]], [[Bivalirudin]] | ||
| Línea 108: | Línea 115: | ||
*[[Desmopressin]] | *[[Desmopressin]] | ||
*[[Glucagon]] | *[[Glucagon]] | ||
*[[Prilocaine]] | |||
*[[Propofol]] | |||
*[[Sodium polystyrene sulfonate]] | |||
*[[Sulfasalazine]] | |||
==Category C Drugs== | ==Category C Drugs== | ||
| Línea 116: | Línea 127: | ||
*[[Gentamicin]], [[Neomycin]], [[Amikacin]], [[Streptomycin]], [[Kanamycin]] | *[[Gentamicin]], [[Neomycin]], [[Amikacin]], [[Streptomycin]], [[Kanamycin]] | ||
*[[Trimethoprim-sulfamethoxazole]] | *[[Trimethoprim-sulfamethoxazole]] | ||
*[[Doxycycline]], [[Minocycline]] | *[[Doxycycline]], [[Minocycline]], [[Tetracycline]], [[Tigecycline]] | ||
*[[Fluconazole]], [[Voriconazole]] | *[[Fluconazole]], [[Voriconazole]] | ||
*[[Primaquine]], [[Hydroxychloroquine]] | *[[Primaquine]], [[Hydroxychloroquine]] | ||
| Línea 128: | Línea 139: | ||
*[[Lithium]] | *[[Lithium]] | ||
*[[Topiramate]] | *[[Topiramate]] | ||
*[[Pentobarbital]] | |||
===Cardiovascular=== | ===Cardiovascular=== | ||
| Línea 149: | Línea 161: | ||
*[[Ibuprofen]] (3rd trimester only, otherwise category C) | *[[Ibuprofen]] (3rd trimester only, otherwise category C) | ||
*[[Meloxicam]] (if >30wks, otherwise category C) | *[[Meloxicam]] (if >30wks, otherwise category C) | ||
*[[Tamoxifen]] | |||
==Category X Drugs== | ==Category X Drugs== | ||
| Línea 161: | Línea 174: | ||
*[[Methylene blue]] | *[[Methylene blue]] | ||
*[[Oxytocin]] | *[[Oxytocin]] | ||
*[[Riociguat]] | |||
*[[Isotretinoin]] | |||
==See Also== | ==See Also== | ||
Revisión actual - 05:43 21 abr 2021
This categorization system has been superseded by the 2015 FDA Pregnancy and Lactation Labeling Rule
Background
- The FDA previously assigned letter categories to medications based on their potential for risk to the fetus
- New drugs approved after the 2015 PLLR will not be assigned a pregnancy category.[1]
Table
| Category | Interpretation | Details |
|---|---|---|
| A | Human studies show no risk | Adequate, well-controlled studies in pregnant women have not shown an increased risk of fetal abnormalities to the fetus in any trimester of pregnancy |
| B | No evidence of risk in studies | Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester. |
| C | Risk cannot be ruled out | Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women. |
| D | Positive evidence of risk | Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective. |
| X | Contraindicated in pregnancy | Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant. |
Category A Drugs
- Thiamine, Pyridoxine, Folic acid
- Docusate, Senna, Bisacodyl
- Dextromethorphan
- Doxylamine
- Levothyroxine
- Isoniazid
Category B Drugs
Antibiotics
- Penicillin V, Penicillin G Benzathine, Amoxicillin, Amoxicillin/Clavulanate, Oxacillin, Ampicillin, Ampicillin/Sulbactam, Ticarcillin/Clavulanate, Dicloxacillin, Cloxacillin, Nafcillin
- Ceftriaxone, Cephalexin, Cefazolin, Cefepime, Cefuroxime, Ceftaroline fosamil, Cefdinir, Cefadroxil, Cefpodoxime, Cefprozil, Ceftolozane/tazobactam, Cefditoren
- Clindamycin, Azithromycin, Erythromycin, Fidaxomicin, Spiramycin
- Metronidazole
- Daptomycin
- Nitrofurantoin, Fosfomycin
- Aztreonam, Meropenem, Ertapenem, Doripenem
- Mupirocin
- Quinupristin/dalfopristin
Other Antimicrobials
- Acyclovir, Famciclovir
- Valacyclovir
- Amphotericin B
- Clotrimazole (topical, vulvovaginal)
- Terbinafine
- Mefloquine
- Permethrin
- Emtricitabine/tenofovir (Truvada)
- Nitazoxanide
- Praziquantel
- Raxibacumab
Antiemetics and other GI medications
- Metoclopramide
- Ondansetron
- Dimenhydrinate
- Famotidine
- Lansoprazole, Pantoprazole
- Lactulose, Psyllium
- Loperamide
- Dicyclomine
- Ursodiol
- Sucralfate
Analgesics and other neuro/psych meds
- Acetaminophen
- Ketamine
- Meperidine
- Cyclobenzaprine
- Indomethacin
- Meclizine
- Clozapine
- Benztropine
- Buspirone
- Methylphenidate
Cardiovascular Medications
- Hydrochlorothiazide
- Fenoldopam
- Torsemide, Ethacrynic acid, Amiloride
- Epoprostenol (prostacyclin)
- Sildenafil
- Dobutamine
- Sotalol
Antiplatelet and Anticoagulants
- Clopidogrel, Prasugrel
- Eptifibatide
- Ticlopidine
- Tirofiban
- Apixaban
- Argatroban, Bivalirudin
- Fondaparinux
- Enoxaparin
Antidotes
Miscellaneous
- Ipratropium, Budesonide
- Ranitidine, Cimetidine
- Metformin
- Oxybutynin, Tamsulosin, Phenazopyridine
- Bromocriptine
- Glycopyrrolate
- Montelukast
- Desmopressin
- Glucagon
- Prilocaine
- Propofol
- Sodium polystyrene sulfonate
- Sulfasalazine
Category C Drugs
Includes most medications not listed elsewhere here
Category D Drugs
Antimicrobials
- Gentamicin, Neomycin, Amikacin, Streptomycin, Kanamycin
- Trimethoprim-sulfamethoxazole
- Doxycycline, Minocycline, Tetracycline, Tigecycline
- Fluconazole, Voriconazole
- Primaquine, Hydroxychloroquine
AEDs and other neuro/psych meds
- Phenytoin, Fosphenytoin
- Carbamazepine
- Midazolam, Alprazolam, Clonazepam, Diazepam
- Phenobarbital
- Magnesium sulfate (despite being drug-of-choice for eclampsia!)
- Lithium
- Topiramate
- Pentobarbital
Cardiovascular
- Amiodarone
- Atenolol
- Lisinopril, Captopril, Enalapril, Benazepril
- Losartan, Valsartan
- Aspirin (3rd trimester)
- Edoxaban
- Warfarin
Miscellaneous
- Cortisone, Flunisolide
- Mycophenolate mofetil
- Penicillamine
- Methimazole, Propylthiouracil, Potassium iodide
- Hydroxyurea
- Zoledronate
- Bismuth subsalicylate (3rd trimester only)
- Cyclophosphamide
- Ibuprofen (3rd trimester only, otherwise category C)
- Meloxicam (if >30wks, otherwise category C)
- Tamoxifen
Category X Drugs
- Valproate
- Methotrexate
- Ribavirin
- Triazolam
- Bosentan
- Aliskiren
- Emergency contraception: Levonorgestrel, Ulipristal
- Griseofulvin
- Methylene blue
- Oxytocin
- Riociguat
- Isotretinoin
See Also
External Links
References
- ↑ Brucker MC, King TL. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule. J Midwifery Womens Health. 2017;62(3):308-316. doi:10.1111/jmwh.12611